These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 1635461)

  • 1. Industrial Genetic Toxicology Discussion Group. Report of the meeting on 'Practical Experiences with Regulatory Mutagenicity Guidelines'.
    Brooks T
    Mutagenesis; 1992 Jan; 7(1):87-8. PubMed ID: 1635461
    [No Abstract]   [Full Text] [Related]  

  • 2. Genetic toxicology testing requirements: official and unofficial views from Europe.
    Kirkland DJ
    Environ Mol Mutagen; 1993; 21(1):8-14; discussion 46-57. PubMed ID: 8419157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The outer limits of FDA inspections.
    Scarlett T
    J Parenter Sci Technol; 1991; 45(4):204-8. PubMed ID: 1770416
    [No Abstract]   [Full Text] [Related]  

  • 4. Streamlined chemical tests rebuffed.
    Gilbert N
    Nature; 2010 Jan; 463(7278):142-3. PubMed ID: 20075888
    [No Abstract]   [Full Text] [Related]  

  • 5. Deal on toxicity law fails to appease.
    Abbott A
    Nature; 2005 Nov; 438(7067):406. PubMed ID: 16306952
    [No Abstract]   [Full Text] [Related]  

  • 6. The challenges of process analytical technologies in chemical development.
    Grosso JA; Landau RN; Confalone PN
    Curr Opin Drug Discov Devel; 2005 Nov; 8(6):682-3. PubMed ID: 16312144
    [No Abstract]   [Full Text] [Related]  

  • 7. Data gaps threaten chemical safety law.
    Gilbert N
    Nature; 2011 Jul; 475(7355):150-1. PubMed ID: 21753825
    [No Abstract]   [Full Text] [Related]  

  • 8. Improving chemical safety in the life sciences industry.
    Holland R; Nitsche C
    Drug Discov Today; 2015 Oct; 20(10):1161-2. PubMed ID: 26239428
    [No Abstract]   [Full Text] [Related]  

  • 9. Where will genetic toxicology testing be in 30 years' time? Summary report of the 25th Industrial Genotoxicity Group Meeting, Royal Society of Medicine, London, November 9, 2011.
    Ellis P; Fowler P; Booth E; Kidd D; Howe J; Doherty A; Scott A
    Mutagenesis; 2014 Jan; 29(1):73-7. PubMed ID: 24334751
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shouldn't enantiomeric purity be included in the 'minimum information about a bioactive entity'?
    Lentini G
    Nat Rev Drug Discov; 2012 Sep; 11(9):730; author reply 730. PubMed ID: 22935805
    [No Abstract]   [Full Text] [Related]  

  • 11. U.S. companies get nervous about EU's REACH.
    Thacker PD
    Environ Sci Technol; 2005 Apr; 39(8):171A-172A. PubMed ID: 15884328
    [No Abstract]   [Full Text] [Related]  

  • 12. Scientific evidence and the courts.
    Green MD
    Science; 1993 Dec; 262(5140):1630-1. PubMed ID: 8259498
    [No Abstract]   [Full Text] [Related]  

  • 13. The weight of evidence.
    Nature; 2010 Apr; 464(7292):1103-4. PubMed ID: 20414265
    [No Abstract]   [Full Text] [Related]  

  • 14. [Current status of industrial chemical exposure level management].
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2003 Aug; 21(4):317-9. PubMed ID: 14761469
    [No Abstract]   [Full Text] [Related]  

  • 15. Minimum information about a bioactive entity (MIABE).
    Orchard S; Al-Lazikani B; Bryant S; Clark D; Calder E; Dix I; Engkvist O; Forster M; Gaulton A; Gilson M; Glen R; Grigorov M; Hammond-Kosack K; Harland L; Hopkins A; Larminie C; Lynch N; Mann RK; Murray-Rust P; Lo Piparo E; Southan C; Steinbeck C; Wishart D; Hermjakob H; Overington J; Thornton J
    Nat Rev Drug Discov; 2011 Aug; 10(9):661-9. PubMed ID: 21878981
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory policy. Congress moves toward strengthening EPA's hand on chemical safety.
    Stokstad E
    Science; 2010 Apr; 328(5977):417. PubMed ID: 20413468
    [No Abstract]   [Full Text] [Related]  

  • 17. Establishing best practise in the application of expert review of mutagenicity under ICH M7.
    Barber C; Amberg A; Custer L; Dobo KL; Glowienke S; Van Gompel J; Gutsell S; Harvey J; Honma M; Kenyon MO; Kruhlak N; Muster W; Stavitskaya L; Teasdale A; Vessey J; Wichard J
    Regul Toxicol Pharmacol; 2015 Oct; 73(1):367-77. PubMed ID: 26248005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety evaluation of industrial chemicals in the context of the European region of WHO.
    Tarkowski S
    J Toxicol Sci; 1987 May; 12(2):185-94. PubMed ID: 3625814
    [No Abstract]   [Full Text] [Related]  

  • 19. Concept for the sequential testing of industrial chemicals.
    Gelbke HP
    J Toxicol Sci; 1987 May; 12(2):253-8. PubMed ID: 3625821
    [No Abstract]   [Full Text] [Related]  

  • 20. Science and law. When scientific research and legal practice collide.
    Camilli R; Bowen A; Reddy CM; Seewald JS; Yoerger DR
    Science; 2012 Sep; 337(6102):1608-9. PubMed ID: 23019634
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.